Product logins

Find logins to all Clarivate products below.


Breast Biopsy Devices | Market Insights | Global | 2017

The moderate growth of the global breast biopsy device market will be driven primarily by the increasing awareness of breast cancer screening in developing markets like China and India, the ongoing shift toward CNB devices in rural areas across different geographies, and the shift toward premium-priced VAB devices in urban areas of developed markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the breast biopsy device market in the US, Europe, and Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Biopsy Devices – Market Insights – Europe (Supplemental)
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – Europe
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – United States
The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…
Report
Biopsy Devices | Market Insights | Europe (Supplemental) | 2024
The European biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2032, driven by rise in…
Report
Biopsy Devices | Market Insights | Europe | 2024
The European biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2032, driven by rise in…